论文部分内容阅读
近20年来新辅助化疗作为一种新的化疗理念已经逐渐被临床工作者所接受,已经越来越广泛的应用于恶性肿瘤的临床治疗。特别是在乳腺癌的治疗中有更广泛的应用。虽然在乳腺癌领域,新辅助化疗是否能提高总生存率尚存在争议,但其对降低病期,争取保乳机会筛选敏感的化疗药物和抑制外
Neoadjuvant chemotherapy as a new concept of chemotherapy has gradually been accepted by clinicians in recent 20 years and has been used more and more widely in the clinical treatment of malignant tumors. Especially in the treatment of breast cancer has more extensive application. Although in the field of breast cancer, whether neoadjuvant chemotherapy can improve the overall survival rate is still controversial, but it is to reduce the disease period, to fight breast-feeding opportunity to screen for sensitive chemotherapeutic drugs and inhibition